Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio, Riken to Provide Free Software to Researchers in Earthquake, Tsunami Area

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CLC Bio Japan said today it is collaborating with Riken Omics Science Center to expand its Japanese outreach program in the Tohoku earthquake and tsunami disaster area.

As a result, free licenses for CLC Main Workbench will be provided to all academic organizations in the area. The licenses being donated by CLC Bio Japan, a subsidiary of CLC Bio, will be owned forever by the organizations. The company will also provide full support and upgrades for the first full year after installation of the licenses.

Afterward, organizations will need to opt into CLC Bio's Maintenance and Support program to continue receiving upgrades and support, the company said.

In a statement, David Leangen, CEO of CLC Bio Japan, said that "[p]roviding free software obviously doesn't compensate for losing your home, but at least in some small way we can help the research institutions in the area get back on their feet."

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.